このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Personalised Activity Plan for BREAKing UP Sitting Time in Patients With Peripheral Arterial Disease and Intermittent Claudication (The BREAK UP Study) (BREAK UP)

2022年3月9日 更新者:University of Leicester

Intermittent claudication is the most common manifestation of peripheral arterial disease, a common cardiovascular disease that causes blocked blood vessels (arteries) in the leg. Symptoms consist of persistent pain in one or both legs during exercise that is relieved with rest. Evidence suggests that high levels of uninterrupted sitting and sedentary behaviour are associated with cardiovascular disease risk, mortality and all-cause mortality. One of the main goals for treating people with intermittent claudication, is increased participation in physical activity. Supervised Exercise Programmes are recommended however these are not well tolerated and compliance is low. Alternative exercise, including short bouts of physical activity to break up sedentary time, has been suggested to help improve physical function.

This study will investigate whether alternative exercise, in the form of breaking up prolonged sitting time, will improve physical function in patients with intermittent claudication.

Patients will be screened during their routine clinic appointment at Glenfield Hospital. All other study activity will take place at the patients home.

Activity monitors will be worn for up to 8 days at baseline and follow-up, measuring step count and time, inactivity, activity time and intensity, and sleep duration. Participants will also be expected to wear activity monitors for the duration of the 8-week intervention to measure steps. Participants will be in the study for up to 18 weeks in total.

調査の概要

詳細な説明

Due to COVID-19 restrictions, the BREAK UP study is being conducted as an 8-week home-based before and after intervention study with the aim to improve physical function measured via the WIQ; and to reduce sitting time by up to 60 minutes per day, seven days a week.

Participants will be required to make contact with members of the research team twice to complete assessments remotely, once to complete a coaching consultation, and once per week during the 8-week activity plan to discuss their performance. Organisation of these, and any contact associated with recruitment may require more frequent contact with the research team via telephone or email.

Contact 1 (Recruitment/ eligibility):

Expression of interest to participate will be sought by the treating clinician at Glenfield hospital (listed on the delegation log), who will offer the patient a Participant Information Sheet, contact details form to complete and a consent form. The patient may then be approached by a member of the research team to take their consent, having read the information sheet, or if the participant is happy to be, a member of the research team will contact them within two weeks via telephone and/or email the participant to discuss the study in more detail and determine if they wish to participate or not. After which, they will be asked to complete the consent form and post this back to the research team. Once the signed and dated consent forms have been received, the researcher can organise for the baseline data to be collected.

Contact 2 (Baseline assessments):

Within 2 weeks participants will be required to complete baseline assessments which includes information on their date of birth/age, sex, ethnicity, smoking status, alcohol consumption, medical history (co-morbidities) and a number of questionnaires to assess their quality of life, breathlessness, anxiety and depression, fatigue and physical function. These will be completed over the telephone with the researcher or the researcher will post the questionnaires to the participants which will need to be completed and returned by post. These assessments will take approximately 1 hour.

Participants will also be posted two activity monitors (monitor 1 and 2) one of which will be wrist worn and the other thigh worn, as well as information on how to fit these. Participants will wear these for a period of up to 8 days to collect habitual physical activity data. A daily sleep-wake log will be used to collect data on participants sleep and wake-time, which will be posted, along with instructions on how to complete these, and returned via post along with the activity monitors.

Contact 3 (Coaching consultation):

Within 2 weeks participants will receive a telephone or video call which will be termed a "coaching consult", during which fourteen 2-minute activities to break sitting time will be discussed with a member of the research team. Video tutorials and/or instruction cards of these activities will be sent via post prior to the coaching consult. These activities and data from the habitual physical activity measure will be used to inform personalised activity plans whereby participants will be encouraged, using Bandura's social cognitive theory, to use these activities to reduce sitting time by up to 60 minutes per day for 8-weeks. This contact will take approximately 15 minutes. The 8-week activity plan will be prescribed, to complete at home and will begin within 2 weeks of this contact.

Participants will wear a wrist-worn activity monitor for the duration of the home-based 8-week intervention (monitor 3). They will be instructed on how to use these during the coaching consultation and how to complete daily diaries for monitor wear and activity completion for the 8-week period.

During the 8-week intervention participants will be contacted once a week via telephone or video to discuss their performance on the activity plan and completion of the daily diary. This will take approximately 15 minutes a week. A member of the research team will organise this over email or telephone.

A second 8-day habitual physical activity measurement period will take place during week 8 of the intervention. Activity monitors 1 and 2 will be posted to participants in good time along with instructions on how to fit these. During this second habitual physical activity measurement period participants will continue to wear wrist-worn activity monitor 3 as well.

Contact 4 (Follow-up):

Participants will then be contacted for their final assessments within one week of the end of the 8-week intervention. The follow-up assessments will include the same assessments as at baseline, except for one questionnaire, and will be completed via telephone with a member of the research team, or a researcher will be post these out to the participant for completion. The assessments will take approximately 1 hour.

研究の種類

介入

入学 (予想される)

35

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Leicester、イギリス、LE3 9QP
        • 募集
        • J Perks
        • コンタクト:
        • コンタクト:
        • 主任研究者:
          • Rob Sayers

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Men and women
  • Age ≥18 years
  • ABPI <0.9 or >1.4 at rest OR >20% decrease post exercise. When ABPI is >0.9 but there is clinical suspicion of PAD, other non-invasive tests, which may include imaging, will be used to confirm diagnosis.
  • History of intermittent claudication (exercise induced, aching/cramping, pain affecting the lower limbs or buttocks, which subsides with rest)
  • Able and willing to give informed consent
  • Able to speak, read, and write English
  • Able to undertake light physical activity

Exclusion Criteria:

  • Individuals with type 1, gestational, or monogenic diabetes mellitus
  • On insulin therapy
  • Hospital admission in preceding 3 months
  • Current or planned pregnancy, or breast feeding
  • Contra-indications to exercise
  • Participation in CTIMP currently and/or in preceding 3 months
  • Already participating in a structured SEP
  • Serious illness with life-expectancy < 1 year
  • Previous major amputation
  • Recent cardiovascular event (within the last 12 months)
  • Comorbidity that the research team considered to be a contraindication to involvement in the study
  • Unable to communicate in English
  • Recent diagnosis or treatment for cancer (within 12 months)

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:なし
  • 介入モデル:単一グループの割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Experimental
Participants will take part in an 8-week home-based activity plan to break up sitting time by 60 minutes per day.
This research study aims to prove efficacy of a home-based physical activity intervention targeted at reducing periods of prolonged sitting and improving physical function in patients with intermittent claudication.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
To investigate overall changes in sitting time
時間枠:8 weeks
Measured using accelerometers (comparison of time spent sitting at baseline vs. follow-up assessed via acceleration)
8 weeks
The walking impairment questionnaire
時間枠:8 weeks
Total score for 16 questions measuring walking distance, speed and stair climbing from 0 (worst/inability) to 4 (best/without limitations)
8 weeks

二次結果の測定

結果測定
メジャーの説明
時間枠
To investigate overall changes in time spent performing physical activity
時間枠:8 weeks
Measured using accelerometers (comparison of time spent performing physical activity at baseline vs. follow up assessed via mean acceleration mg/day )
8 weeks
To investigate overall changes in time spent in light physical activity
時間枠:8 weeks
Measured using accelerometers (comparison of time spent in light physical activity at baseline vs. follow up assessed via acceleration mins/day)
8 weeks
To investigate overall changes in time spent in moderate physical activity
時間枠:8 weeks
Measured using accelerometers (comparison of time spent in moderate physical activity at baseline vs. follow up assessed via acceleration mins/day)
8 weeks
To investigate overall changes in time spent in vigorous physical activity
時間枠:8 weeks
Measured using accelerometers (comparison of time spent in vigorous physical activity at baseline vs. follow up assessed via acceleration mins/day)
8 weeks
To investigate overall changes in time spent in prolonged sitting
時間枠:8 weeks
Measured using accelerometers (comparison of time spent sitting at baseline vs. follow-up assessed via acceleration)
8 weeks
To investigate overall changes in time spent in sleep
時間枠:8 weeks
Measured using accelerometers (comparison of time spent sleeping at baseline vs. follow-up assessed via acceleration)
8 weeks
To investigate whether personalised activity breaks in sitting time improve quality of life
時間枠:8 weeks
Measured using the Vascular Quality of Life (VascuQoL) questionnaire
8 weeks
To investigate whether personalised activity breaks in sitting time improve quality of life
時間枠:8 weeks
Measured using the Euro Quality of Life (EQ-5D-5L) questionnaire
8 weeks
To investigate whether personalised activity breaks in sitting time improve breathlessness
時間枠:8 weeks
Measured using the modified medical research council (mMRC) dyspnoea scale
8 weeks
To investigate whether personalised activity breaks in sitting time improve fatigue
時間枠:8 weeks
Measured using Chalder's Fatigue Scale
8 weeks
To investigate whether personalised activity breaks in sitting time improve anxiety and depression
時間枠:8 weeks
Measured using the hospital anxiety and depression scale
8 weeks

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2021年3月31日

一次修了 (予想される)

2022年10月1日

研究の完了 (予想される)

2022年10月1日

試験登録日

最初に提出

2020年9月14日

QC基準を満たした最初の提出物

2020年9月30日

最初の投稿 (実際)

2020年10月1日

学習記録の更新

投稿された最後の更新 (実際)

2022年3月14日

QC基準を満たした最後の更新が送信されました

2022年3月9日

最終確認日

2022年3月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

Once we have analysed the results, we will present our findings at scientific meetings and publish in medical research journals. All these results will be anonymous, and it would not be possible to identify participants.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • SAP
  • CSR

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する